Comprehensive Unit-based Safety

Timmel, J., Kent, P.S., Holzmueller, C.G., Paine, L., Schulick, R.D. andPronovost, P.J. 2010. Impact of the Comprehensive Unit-Based Safety Program (CUSP) on safety culture in a surgical inpatient unit. Joint Commission Journal on Quality and Patient Safety, 36, 252-60. 

In a 14-bed oncology surgical intensive care unit (ICU) and a I S-bed surgical ICU within a 900-bed academic medical center, implement a comprehensive unit-based safety program that empowers staff to identify and eliminate patient safety hazards following eight action steps. 

To determine the industries likely to use a chemical, the Kirk-Othmer Encyclopedia of Chemical Technology, the Organic Chemical Producers Data Base, and the National Occupational Hazard Survey may be of help. This last source represents the only comprehensive industrial exposure survey. Under its mandate in the Occupational Safety and Health Act of 1970, NIOSH conducted a two and a half year statistically structured survey of United States workplaces to determine the levels of chemicals, trademark products, or physical agents to which workers were being exposed by job title. The Inventory of Chemicals in Commerce recently assembled by EPA s Office of Toxic Substances also contains data on chemical production by site as well as a coded production volume. EPA can also use Section 8 of TSCA to collect chemical use data, but has not done so to date. 

As the above addressed examples show, upgrading of NPP in Ukraine is many-sided problem requiring comprehensive and in-depth investigation. The RA faces with the proper assessment of the decisions made in terms of their impact upon safety of NPP, well grounded bases, possibility and expediency of their implementation. Substantial role as to this assessment is played by SSTC NRS. Scientific support to the RA allows to take into account both the newest study results under making of decision and the experience gained during previous operation of units for many years. 

Preclinical studies are a vital first step to assess the safety and quality of ingredients new to infant formulas. Regulatory guidelines for preclinical studies must be based on considerations of the diversity of the potential new ingredients and the ingredients source and matrix. In the United States, the FDA Redbook provides comprehensive guidelines for conducting preclinical studies to test the safety of food and color additives, but it often does not take the many special needs and vulnerabilities of infants into consideration. 

---